by Margaret Curnutte
European School of Molecular Medicine (SEMM) at the Campus IFOM-IEO (Milano), University of Milano &
Harvard Program on Science, Technology & Society
FondazioneGianninoBassetti
16 May 2011
The global precision medicine market was valued at USD 50.99 billion in 2018 and is projected to reach USD 88.25 billion by 2023, growing at a CAGR of 11.60%. The market is segmented by ecosystem players, therapeutics, and technology, with cancer being the largest therapeutic segment. Key drivers of growth include increasing investments in precision medicine R&D, rising prevalence of chronic diseases, and advancements in technologies such as genomics, big data analytics, and companion diagnostics.
Tele-Health Carts, Servers, and Monitoring: Market Shares, Strategies, and Fo...ReportsnReports
The document provides details about a report on the tele-health carts, servers, and monitoring market from 2012 to 2018. It analyzes market shares and forecasts, strategies of major companies, and discusses how tele-health improves treatment of chronic diseases and reduces healthcare costs. The global tele-health equipment market is expected to grow rapidly due to improving care for patients with chronic conditions through more standardized remote monitoring and treatment. Major companies discussed include Bosch, Bayer, Philips, Honeywell, and GlobalMed.
This document discusses different aspects of outcomes research. It describes outcomes research as studying the effects of care and treatments on individuals and populations. It discusses two organizations that conduct outcomes research - the Agency for Healthcare Research and Quality (AHRQ) and the Patient-Centered Outcomes Research Institute (PCORI). AHRQ focuses on issues like reducing antibiotic overuse and opioid addiction treatment. PCORI emphasizes helping patients make informed healthcare decisions. The document also notes some positive impacts of this research, like AHRQ's work on the opioid epidemic and infection control, as well as PCORI's focus on patient decision making. However, it critiques one PCORI study as possibly wasteful for not ensuring both study
The document discusses the need for payment reform in the US healthcare system. It notes that the current system provides little incentive for prevention, quality, or efficiency. It presents data showing higher healthcare spending and worse health outcomes in the US compared to other developed countries. The document advocates aligning payment incentives with goals of wellness, care coordination, and evidence-based practices. It presents several potential payment models and delivery system reforms to work toward a higher performing system.
Presentation - Northern Health Research ConferenceSuzanne McGuire
This document discusses a study measuring patient use of an electronic patient portal (EPP) called myCARE at the Group Health Centre (GHC) in Sault Ste. Marie, Ontario. The study will analyze demographic data and interview patients to understand who uses the portal and their motivations for use or non-use. Common EPP users tend to be computer-literate Caucasian females with chronic conditions. The goal is to evaluate myCARE's value and how to increase portal enrollment and usage to benefit patients and GHC.
CMS Announces Change to Payment Structure for Medicare Part B Drugs By Floyd ...Floyd Arthur
- The Centers for Medicare and Medicaid Services (CMS) has proposed a change to the payment structure for Medicare Part B drugs administered in outpatient settings like physicians' offices.
- Currently, CMS reimburses physicians the average sale price of a drug plus a 6% add-on fee, which CMS says encourages the use of high-priced drugs even when lower-cost options are available.
- The proposed new model would reimburse physicians the average sale price plus a 2.5% add-on fee and a flat $16.80 per drug, per day fee, aiming to improve quality and value. However, some oncology groups argue this could compromise patient care.
The document discusses how health information technology (HIT) such as electronic health records (EHRs), communication technologies, and health information exchanges (HIEs) can improve community health outcomes. EHRs allow providers to better monitor patients, provide more accurate care through features like e-prescribing, and improve outcomes with clinical decision support systems. Communication technologies enhance care for rural and very ill patients. HIEs facilitate information sharing between providers to improve continuity of care and submit data to immunization registries and public health agencies. Overall, the document argues that HIT has great potential to advance community health if these technologies are utilized effectively.
The global precision medicine market was valued at USD 50.99 billion in 2018 and is projected to reach USD 88.25 billion by 2023, growing at a CAGR of 11.60%. The market is segmented by ecosystem players, therapeutics, and technology, with cancer being the largest therapeutic segment. Key drivers of growth include increasing investments in precision medicine R&D, rising prevalence of chronic diseases, and advancements in technologies such as genomics, big data analytics, and companion diagnostics.
Tele-Health Carts, Servers, and Monitoring: Market Shares, Strategies, and Fo...ReportsnReports
The document provides details about a report on the tele-health carts, servers, and monitoring market from 2012 to 2018. It analyzes market shares and forecasts, strategies of major companies, and discusses how tele-health improves treatment of chronic diseases and reduces healthcare costs. The global tele-health equipment market is expected to grow rapidly due to improving care for patients with chronic conditions through more standardized remote monitoring and treatment. Major companies discussed include Bosch, Bayer, Philips, Honeywell, and GlobalMed.
This document discusses different aspects of outcomes research. It describes outcomes research as studying the effects of care and treatments on individuals and populations. It discusses two organizations that conduct outcomes research - the Agency for Healthcare Research and Quality (AHRQ) and the Patient-Centered Outcomes Research Institute (PCORI). AHRQ focuses on issues like reducing antibiotic overuse and opioid addiction treatment. PCORI emphasizes helping patients make informed healthcare decisions. The document also notes some positive impacts of this research, like AHRQ's work on the opioid epidemic and infection control, as well as PCORI's focus on patient decision making. However, it critiques one PCORI study as possibly wasteful for not ensuring both study
The document discusses the need for payment reform in the US healthcare system. It notes that the current system provides little incentive for prevention, quality, or efficiency. It presents data showing higher healthcare spending and worse health outcomes in the US compared to other developed countries. The document advocates aligning payment incentives with goals of wellness, care coordination, and evidence-based practices. It presents several potential payment models and delivery system reforms to work toward a higher performing system.
Presentation - Northern Health Research ConferenceSuzanne McGuire
This document discusses a study measuring patient use of an electronic patient portal (EPP) called myCARE at the Group Health Centre (GHC) in Sault Ste. Marie, Ontario. The study will analyze demographic data and interview patients to understand who uses the portal and their motivations for use or non-use. Common EPP users tend to be computer-literate Caucasian females with chronic conditions. The goal is to evaluate myCARE's value and how to increase portal enrollment and usage to benefit patients and GHC.
CMS Announces Change to Payment Structure for Medicare Part B Drugs By Floyd ...Floyd Arthur
- The Centers for Medicare and Medicaid Services (CMS) has proposed a change to the payment structure for Medicare Part B drugs administered in outpatient settings like physicians' offices.
- Currently, CMS reimburses physicians the average sale price of a drug plus a 6% add-on fee, which CMS says encourages the use of high-priced drugs even when lower-cost options are available.
- The proposed new model would reimburse physicians the average sale price plus a 2.5% add-on fee and a flat $16.80 per drug, per day fee, aiming to improve quality and value. However, some oncology groups argue this could compromise patient care.
The document discusses how health information technology (HIT) such as electronic health records (EHRs), communication technologies, and health information exchanges (HIEs) can improve community health outcomes. EHRs allow providers to better monitor patients, provide more accurate care through features like e-prescribing, and improve outcomes with clinical decision support systems. Communication technologies enhance care for rural and very ill patients. HIEs facilitate information sharing between providers to improve continuity of care and submit data to immunization registries and public health agencies. Overall, the document argues that HIT has great potential to advance community health if these technologies are utilized effectively.
Opioid epidemic has become a public health emergency in the United States, with authorities, researchers and doctors trying to find ways to lessen its impact. Under such circumstances, each initiative matters.
Patient-generated data is health-related data created by patients to help manage their condition, including symptoms, medication adherence, and biometric data from wearable devices. This data is distinct from clinical data as it is recorded by patients outside of healthcare settings. Technologies allow widespread collection of patient data to improve monitoring and research. However, ensuring high quality, standardized data sharing while protecting patient privacy and engaging patients requires governance plans and may require significant resources from patient organizations.
HXR 2016: Improving Insurance Member Experiences -Janna Kimel, CambiaHxRefactored
This section of the agenda will feature leaders in innovation, customer experience, and design within the health insurance space. Each panelist will present the current state of experience at their organization, what successes they have seen, what situations they have learned from, and what their challenges and obstacles are, and where they would like to see things head in the future. Then Amy Cueva will guide the group in a discussion around strategy, measurement, culture change, and other important topics relevant to delivering phenomenal experiences.
The Pennsylvania Patient Safety Authority estimates that more than 2,600 lives and $147 million have been saved from 2004 to 2015 through improved patient safety efforts across Pennsylvania. Certain measures showing concentrated safety improvements, such as reductions in falls, infections, and wrong-site surgeries, were analyzed using the Authority's reporting data and estimates of prevented deaths and costs. While progress has been made, the Authority acknowledges more work is still needed to enhance patient safety.
Telemedicine Guidelines for Indian DoctorsAnup Soans
Registered medical practitioners in India are now permitted to provide telemedicine consultations according to new guidelines issued by the Board of Governors in supersession of the Medical Council of India. [1] The guidelines define telemedicine and provide standards for its practice using various technologies and modes of communication. [2] All medical practitioners wishing to provide teleconsultations must complete an online training course on telemedicine. [3] The guidelines aim to expand access to healthcare while maintaining standards of medical ethics.
Outcomes research studies the effects of healthcare treatments and interventions on individuals and populations. The Agency for Healthcare Research and Quality (AHRQ) and the Patient-Centered Outcomes Research Institute (PCORI) both conduct outcomes research but with different goals. AHRQ aims to improve healthcare quality while PCORI provides patients with information on treatment effectiveness to aid healthcare decisions. Examples show AHRQ researching the opioid crisis while PCORI examines opioid prescribing guidance, with both focusing on useful outcomes for patients.
1) The document discusses establishing community awareness and fundraising for the Health Information Technology Solutions for Kids (HITS for kids) program. This program has developed apps and software to help doctors better diagnose and treat concussions in children without unnecessary CT scans.
2) The team launched a social media campaign including a Facebook page and created materials to promote their annual Race for Every Child 5k to raise awareness about the program.
3) Moving forward, HITS for kids plans to expand their social media presence and participate in more advocacy and community outreach to spread awareness of their diagnostic tools for concussions to more hospitals nationwide.
> Patient engagement
> Patient advocacy groups
> Patient focused drug development
> Patient reported outcomes
> Patient centric clinical trials
> Patient preference studies
> Make patients as partners in research
> Institutionalised involvement - NICE, EMA, US-FDA
> Indian perspective
> Drivers for involving patients
This infographic speaks to the challenges Emergency Departments face in caring and following up with the growing population of patients they see, and demonstrates how some EDs are seeing measurable improvements in care, patient satisfaction and efficiency.
Building Patient-Centeredness in the Real World: The Engaged Patient and the ...EngagingPatients
This paper examines the separate but intertwined ethical, economic and clinical concepts of patientcenteredness and how ACOs provide a structure for turning those concepts into a functioning reality.
The document discusses improving the quality of medical decisions through shared decision making. It finds that currently many patients are not well informed about their medical options and risks when consenting to procedures. Shared decision making models aim to have clinicians and patients work together to make informed and values-based choices. Research shows patient decision aids that provide balanced information on options can improve decision quality by increasing patient knowledge and engagement in the process.
The study tested an electronic diabetes tracker shared between patients and providers to improve diabetes care. Patients in the intervention group had access to the tracker and decision support. They saw greater improvements in monitoring of diabetes factors and clinical outcomes like blood pressure and HbA1c levels compared to the control group. However, it is unclear if the improvements were due to the decision support, reminders, or more frequent provider visits in the intervention group.
We don’t have a functional competitive market in health care in the U.S. Consequently, many of the attributes of competitive markets that are beneficial in our lives are not present in health care. One significant negative externality of a dysfunctional market is an inability to discern quality. Consumerism is critical. Includes data and analysis from the 5TH ANNUAL HEALTHGRADES PATIENT SAFETY IN AMERICAN HOSPITALS STUDY – APRIL 2008
Does patient engagement result in more appropriate utilization?Benjamin Littenberg
This presentation reviews what published research has established about how patient engagement improves the overall clinical experience and what that means for providers.
This study assessed the use of personal digital assistants (PDAs) in conjunction with electronic medical records (EMRs) by physician assistants (PAs) through a questionnaire sent to recent graduates. Of 122 respondents, 72 used PDAs but only 5 used PDAs with EMRs, suggesting barriers to adoption. Those using PDAs and EMRs perceived benefits like improved quality of care and efficiency. However, adoption of the combined technology lags behind individual adoption, and future research is needed to understand barriers and promote integration.
Mobile companion apps can be used to extend the patient-provider relationship beyond traditional in-person interactions. However, past health apps have often failed because they were disconnected from existing health records and clinical workflows. Effective companion apps would need to integrate with electronic health record systems used by providers and address how doctors would use the apps as part of their existing practices. Developing companion apps can help improve patient engagement, satisfaction, and trust in providers by providing information to patients before and after visits and strengthening the personal connection in healthcare.
Chapter 15 precision medicine in oncologyNilesh Kucha
This document discusses precision medicine in oncology and molecular monitoring of cancer patients. It describes how molecular characterization of tumors can guide treatment decisions and help develop targeted therapies. Next-generation DNA sequencing is allowing large amounts of tumor DNA to be analyzed to identify molecular targets and guide clinical trials matching treatments to tumor mutations. Challenges include limiting sequencing to known targets, accounting for germline variants, incidental findings, and integrating sequencing results into clinical decision making. Repeated biopsies during treatment can provide insights into drug sensitivity and resistance mechanisms in individual patients.
The document discusses Estonia's interoperability framework (IOF) which aims to improve cooperation and information exchange between government organizations. The IOF covers organizational, legal, technical and semantic interoperability. It proposes establishing shared infrastructure and services, aligning legislation, and developing standards and specifications to ensure systems can communicate. The document also lists 28 questions about implementing specific aspects of the IOF such as establishing a government portal, reusing solutions, defining business processes, and creating a personal secure environment for citizens.
The Bassetti Foundation's mission is to promote responsible innovation by addressing actors involved in complex innovation scenarios and increasing awareness of responsibility. The Foundation promotes responsible innovation through political and cultural activities, fostering awareness among entrepreneurs, policymakers, and communicators of the multiple consequences of their decisions regarding innovation. It defines innovation as something previously improbable but now real, forging new links between knowledge and power through previously unknown objects, relations, or situations. The Foundation conducts research, teaching, dissemination activities, and cooperation with academic institutes and businesses on topics related to responsible innovation.
Opioid epidemic has become a public health emergency in the United States, with authorities, researchers and doctors trying to find ways to lessen its impact. Under such circumstances, each initiative matters.
Patient-generated data is health-related data created by patients to help manage their condition, including symptoms, medication adherence, and biometric data from wearable devices. This data is distinct from clinical data as it is recorded by patients outside of healthcare settings. Technologies allow widespread collection of patient data to improve monitoring and research. However, ensuring high quality, standardized data sharing while protecting patient privacy and engaging patients requires governance plans and may require significant resources from patient organizations.
HXR 2016: Improving Insurance Member Experiences -Janna Kimel, CambiaHxRefactored
This section of the agenda will feature leaders in innovation, customer experience, and design within the health insurance space. Each panelist will present the current state of experience at their organization, what successes they have seen, what situations they have learned from, and what their challenges and obstacles are, and where they would like to see things head in the future. Then Amy Cueva will guide the group in a discussion around strategy, measurement, culture change, and other important topics relevant to delivering phenomenal experiences.
The Pennsylvania Patient Safety Authority estimates that more than 2,600 lives and $147 million have been saved from 2004 to 2015 through improved patient safety efforts across Pennsylvania. Certain measures showing concentrated safety improvements, such as reductions in falls, infections, and wrong-site surgeries, were analyzed using the Authority's reporting data and estimates of prevented deaths and costs. While progress has been made, the Authority acknowledges more work is still needed to enhance patient safety.
Telemedicine Guidelines for Indian DoctorsAnup Soans
Registered medical practitioners in India are now permitted to provide telemedicine consultations according to new guidelines issued by the Board of Governors in supersession of the Medical Council of India. [1] The guidelines define telemedicine and provide standards for its practice using various technologies and modes of communication. [2] All medical practitioners wishing to provide teleconsultations must complete an online training course on telemedicine. [3] The guidelines aim to expand access to healthcare while maintaining standards of medical ethics.
Outcomes research studies the effects of healthcare treatments and interventions on individuals and populations. The Agency for Healthcare Research and Quality (AHRQ) and the Patient-Centered Outcomes Research Institute (PCORI) both conduct outcomes research but with different goals. AHRQ aims to improve healthcare quality while PCORI provides patients with information on treatment effectiveness to aid healthcare decisions. Examples show AHRQ researching the opioid crisis while PCORI examines opioid prescribing guidance, with both focusing on useful outcomes for patients.
1) The document discusses establishing community awareness and fundraising for the Health Information Technology Solutions for Kids (HITS for kids) program. This program has developed apps and software to help doctors better diagnose and treat concussions in children without unnecessary CT scans.
2) The team launched a social media campaign including a Facebook page and created materials to promote their annual Race for Every Child 5k to raise awareness about the program.
3) Moving forward, HITS for kids plans to expand their social media presence and participate in more advocacy and community outreach to spread awareness of their diagnostic tools for concussions to more hospitals nationwide.
> Patient engagement
> Patient advocacy groups
> Patient focused drug development
> Patient reported outcomes
> Patient centric clinical trials
> Patient preference studies
> Make patients as partners in research
> Institutionalised involvement - NICE, EMA, US-FDA
> Indian perspective
> Drivers for involving patients
This infographic speaks to the challenges Emergency Departments face in caring and following up with the growing population of patients they see, and demonstrates how some EDs are seeing measurable improvements in care, patient satisfaction and efficiency.
Building Patient-Centeredness in the Real World: The Engaged Patient and the ...EngagingPatients
This paper examines the separate but intertwined ethical, economic and clinical concepts of patientcenteredness and how ACOs provide a structure for turning those concepts into a functioning reality.
The document discusses improving the quality of medical decisions through shared decision making. It finds that currently many patients are not well informed about their medical options and risks when consenting to procedures. Shared decision making models aim to have clinicians and patients work together to make informed and values-based choices. Research shows patient decision aids that provide balanced information on options can improve decision quality by increasing patient knowledge and engagement in the process.
The study tested an electronic diabetes tracker shared between patients and providers to improve diabetes care. Patients in the intervention group had access to the tracker and decision support. They saw greater improvements in monitoring of diabetes factors and clinical outcomes like blood pressure and HbA1c levels compared to the control group. However, it is unclear if the improvements were due to the decision support, reminders, or more frequent provider visits in the intervention group.
We don’t have a functional competitive market in health care in the U.S. Consequently, many of the attributes of competitive markets that are beneficial in our lives are not present in health care. One significant negative externality of a dysfunctional market is an inability to discern quality. Consumerism is critical. Includes data and analysis from the 5TH ANNUAL HEALTHGRADES PATIENT SAFETY IN AMERICAN HOSPITALS STUDY – APRIL 2008
Does patient engagement result in more appropriate utilization?Benjamin Littenberg
This presentation reviews what published research has established about how patient engagement improves the overall clinical experience and what that means for providers.
This study assessed the use of personal digital assistants (PDAs) in conjunction with electronic medical records (EMRs) by physician assistants (PAs) through a questionnaire sent to recent graduates. Of 122 respondents, 72 used PDAs but only 5 used PDAs with EMRs, suggesting barriers to adoption. Those using PDAs and EMRs perceived benefits like improved quality of care and efficiency. However, adoption of the combined technology lags behind individual adoption, and future research is needed to understand barriers and promote integration.
Mobile companion apps can be used to extend the patient-provider relationship beyond traditional in-person interactions. However, past health apps have often failed because they were disconnected from existing health records and clinical workflows. Effective companion apps would need to integrate with electronic health record systems used by providers and address how doctors would use the apps as part of their existing practices. Developing companion apps can help improve patient engagement, satisfaction, and trust in providers by providing information to patients before and after visits and strengthening the personal connection in healthcare.
Chapter 15 precision medicine in oncologyNilesh Kucha
This document discusses precision medicine in oncology and molecular monitoring of cancer patients. It describes how molecular characterization of tumors can guide treatment decisions and help develop targeted therapies. Next-generation DNA sequencing is allowing large amounts of tumor DNA to be analyzed to identify molecular targets and guide clinical trials matching treatments to tumor mutations. Challenges include limiting sequencing to known targets, accounting for germline variants, incidental findings, and integrating sequencing results into clinical decision making. Repeated biopsies during treatment can provide insights into drug sensitivity and resistance mechanisms in individual patients.
The document discusses Estonia's interoperability framework (IOF) which aims to improve cooperation and information exchange between government organizations. The IOF covers organizational, legal, technical and semantic interoperability. It proposes establishing shared infrastructure and services, aligning legislation, and developing standards and specifications to ensure systems can communicate. The document also lists 28 questions about implementing specific aspects of the IOF such as establishing a government portal, reusing solutions, defining business processes, and creating a personal secure environment for citizens.
The Bassetti Foundation's mission is to promote responsible innovation by addressing actors involved in complex innovation scenarios and increasing awareness of responsibility. The Foundation promotes responsible innovation through political and cultural activities, fostering awareness among entrepreneurs, policymakers, and communicators of the multiple consequences of their decisions regarding innovation. It defines innovation as something previously improbable but now real, forging new links between knowledge and power through previously unknown objects, relations, or situations. The Foundation conducts research, teaching, dissemination activities, and cooperation with academic institutes and businesses on topics related to responsible innovation.
The document discusses the design system in Milan and proposes establishing a Milan Design Council to support the design community through increasing institutional support, fostering relationships between designers and entrepreneurs, and promoting intersections between science/technology and design. It analyzes key drivers that could shape Milan's future as a design hub and provides examples of potential projects the Design Council could undertake to strengthen the city's position, such as competitions for startups and initiatives to integrate design education into local schools.
The document outlines a project to promote design in Milan through three main activities:
1) Interviews with 13 influential people in the Milanese design scene to gain insights and perspectives.
2) A "bubble method" serious game where participants mapped the local design system and its evolution over time.
3) The outcomes of the project include key insights about driving design in Milan, photographs depicting the design system, and an evolution of players in the system over time to inform the creation of an action plan and online platform to further support design in the city.
A presentation that tries to set an IPv6 agenda for the SIP community. VoIP and IPv6 is a natural match. If we want unified communication to be truly global and unified - we need to build solutions on IPv6 and not Ipv4.
A short presentation by Olle E. Johansson and Saul Ibarra Corretge for the 4K Conference in Buenos Aires Nov 24 2011. The presentation introduces new SIP standards and a vision about future SIP communication beyond the PBX and the PSTN-model phone.
Presentation for the Voip2day.net conference organized by Avanzada7 in Madrid, Oct 2011. It introduces a few new additions to the SIP framework and points out some ideas for future implementations.
by Margaret Curnutte
European School of Molecular Medicine (SEMM) at the Campus IFOM-IEO (Milano), University of Milano &
Harvard Program on Science, Technology & Society.
The document discusses the relationship between innovation and politics. It argues that innovation is now the driving force in our lives more than politics or economics, as science and technology advance rapidly. However, those who create innovations are also making political decisions and shaping history, whether they intend to or not. The challenges of innovation, such as risk, uncertainty and indeterminacy, contrast with the traditional decision-making processes of democratic politics. Politicians must learn to make choices between uncertain facts and values when it comes to innovations. Experts and politicians need to work together and share responsibility for decisions involving innovations that neither group fully understands.
The document discusses the role of scientific advice in democratic governance. It introduces Wiebe Bijker and his work on the social construction of technology. Bijker examines how scientific authority and advice are questioned in democracies and how power is distributed institutionally. The document also summarizes several lectures given at the Bassetti Foundation on topics like the role of experts in policymaking, public participation in governance of science and technology, and how scientific institutions navigate advisory and democratic roles.
1) SIP clients are responsible for opening and maintaining connections to SIP proxies to allow for bidirectional communication behind NATs.
2) By keeping connections open, clients avoid the significant delays of opening new TCP connections and the even longer delays of discovering connection failures.
3) The SIP proxy uses registration information like the client's UUID and registration IDs to associate multiple registrations from the same device and route traffic over a single open connection.
Asterisk is an Open Source PBX - but how does it support larger installations? Can you scale it up to thousands of users, with hundreds of simultaneous calls? What about failover, backups and the famous blinking lamps? Olle Johansson goes through various models and describes where some of his current projects with strange names - Pinefrog, Pinana, Pinetree and Bufo fits into this picture.
di Alberto Oliverio.
Università La Sapienza di Roma.
Slide per l'intervento tenuto al convegno "Neuroetica. Le grandi questioni"
Padova 5-7 maggio 2010
Realtime communication security - SIP, XMPP and othersOlle E Johansson
A short presentation on issues we face with realtime security - too many solutions and too few customer requirements and a lack of demand on the market.
A quick introduction to OpenVZ, a virtualization platform for Linux that works like FreeBSD jails - it segments a system into different partitions, all running LInux. Each virtual system, container, can run different Linux distributions.
Slides by Cristina Grasseni for "Food For Mind. Mind For Health" conference. Torino, Friday 22nd October 2010.
The event is organized by the IUHPE (International Union for Health Promotion and Education) - CIPES (Italian Confederation for the Promotion of Health and Education) European Centre, and is an initiative of the European Commission's "Roadmap for a better youth health in Europe".
Presentazione della Fondazione Giannino Bassetti.
La mission della Fondazione Bassetti è promuovere l’innovazione responsabile.
La Fondazione intende rivolgersi agli attori coinvolti nei complessi scenari dell'innovazione fornendo strumenti utili a sviluppare strategie e consapevolezza del proprio ruolo in materia di responsabilità dell'innovazione.
Direct To Consumer Genomics and the Future of HealthcareRyan Squire
Richard Sharp, Ph.D., Director of Bioethics Research at the Cleveland Clinic presents on direct-to-consumer genomics and the future of health care.
Dr. Sharp received his training in philosophy and medical ethics at Michigan State University.
Prior to joining the Cleveland Clinic in 2007, Dr. Sharp taught bioethics at Baylor College of Medicine and the National Institute of Environmental Health Sciences, one of the National Institutes of Health (NIH), where he directed the Program in Environmental Health Policy and Ethics.
His research examines the promotion of informed patient decision-making in clinical research, particularly research that involves genetic analyses.
Direct to consumer genetic testing provides ancestry and health risk information directly to consumers but has significant limitations. While it may promote health awareness, unexpected results can be stressful and consumers may make important medical decisions based on inaccurate or incomplete information from unregulated tests. The high rate of false positives seen in confirmatory testing suggests many consumers are receiving incorrect information from these tests. Regulatory bodies have concerns about oversight, accuracy, and inappropriate use of genetic data that could impact consumers.
There are only around 500 geneticists and 2,400 genetic counselors in the U.S. to help integrate genomic medicine into patient care. DNA Direct aims to address this shortage and other barriers through technology solutions that provide education, decision support, and expert guidance to patients, providers, payors, and medical centers. Their programs have shown success in improving patient compliance with genetic screening and understanding of test results.
Johns Hopkins Hospital doctors report that 40%-80% of chronic pain patient are misdiagnosed, and that MRIs and CTs miss pathology 56%-78% of the time, Therefore, during extensive chart reviews of current medical data will produce a classic case of GIGO-garbage in giving garbage out. The need for accurate diagnoses and testing is critical for AI to work.
The document discusses personalized medicine and the company 23andMe. It provides definitions of personalized medicine from various sources emphasizing using genetic information to prevent and treat disease. It outlines the history of genomics projects like the Human Genome Project and HapMap. 23andMe allows customers to learn about their genetics through direct-to-consumer genetic testing. Customers submit a saliva sample and access results online regarding ancestry, traits, and disease risks. 23andMe aims to empower individuals and facilitate research through participant-driven studies. The document discusses examples of genetic insights into conditions like cancer and how pharmacogenetics can guide treatment choices.
Blue Cross Blue Shield of Michigan and Blue Care Network of Michigan are nonprofit health insurers licensed by the Blue Cross Blue Shield Association. The document discusses how consumers want more choice and control over their healthcare, moving away from a reactive treatment model towards proactive health management. It argues that personalized medicine using genomic data and predictive analytics can improve outcomes by matching patients to effective treatments while reducing costs through more efficient care delivery.
Blue Cross Blue Shield of Michigan and Blue Care Network of Michigan are nonprofit health insurers licensed by the Blue Cross Blue Shield Association. The document discusses how consumers want more choice and control over their healthcare, moving away from a reactive treatment model towards proactive health management. It argues that personalized medicine using genomic data and predictive analytics can improve outcomes by matching patients to effective treatments while reducing costs through more efficient care delivery.
This document discusses trends in healthcare in 2016 related to clinical trials and research participation. It notes that new technologies are dramatically increasing the size and scope of clinical trials by making it easier for more people to participate remotely through mobile apps and sensors. Traditional trials typically took a year to recruit 10,000 people across 50 medical centers, while new methods can recruit that number from 30,000 people in just one month.
Genomic investigations often produce more information than is initially expected. Several documents have addressed this issue. While the approaches to the management of incidental findings (IFs) vary, it is usually recommended that the information be disclosed if there is clinical utility and the possibility of prevention or treatment. This leaves unsolved fundamental issues such as the different ways of interpreting clinical utility and countless sources of uncertainty. Guidelines can offer indications but should not be allowed to relieve healthcare professionals of their responsibilities.
2013-04-17: The Promise, Current State, And Future of Personalized MedicineBaltimore Lean Startup
Jeffrey M. Otto discusses the promise, current state, and future of personalized medicine in a presentation. He begins with definitions of key terms like personalized medicine and biomarkers. He then reviews the early promises of personalized medicine in improving diagnoses, drug development, and treatment effectiveness. However, he notes the field has faced challenges in fully achieving these promises. Currently, the Center for Translational Research is taking an integrated approach using electronic health records, biospecimen samples, and statistical analysis to develop predictive signatures to advance personalized medicine. Their goal is to translate scientific discoveries into clinical applications to improve patient outcomes.
The document discusses a lesson plan that covers genetic screening and testing. Over the next 12 lessons, students will learn about genetics topics like inherited disorders, genetic testing, screening, and the ethical issues around how genetic information is used. One lesson focuses on genetic screening and testing, including how genetic information could be misused by insurance companies and discussed the arguments for and against using DNA profiles to determine insurance costs.
Public Health Genomics uses genomics information to benefit public health through more effective personalized preventive care and disease treatments tailored to an individual's genetic makeup. It assesses how genes interact with behavior, diet, and the environment to impact population health. Key applications of genomics include drug discovery and development through target identification, biomarker analysis to understand disease pathways, and stem cell research. However, challenges include evaluating new genetic tests and monitoring their use and outcomes in populations.
Make DNA data actionable - Festival of Genomics London 2018Omar Fogliadini
The document discusses the emerging field of genomic medicine and direct-to-consumer genetic testing. It notes that the cost of genome sequencing has dropped dramatically in recent years, enabling more people to access their genetic data. However, most doctors currently lack training in genomics and the implications of genetic testing. The development of genomic medicine will require greater integration of genetics into healthcare systems and medical education. The document also examines some of the challenges in ensuring patients and doctors can properly understand and act on genetic results.
Outcomes research examines the end results of health services on individuals and populations in order to provide scientific evidence to support healthcare decisions. It can be categorized into care-related research, patient-related research, and performance-related research. The Agency for Healthcare Research and Quality and the Patient-Centered Outcomes Research Institute both fund outcomes research. Examples of potentially helpful areas for outcomes research include reducing opioid abuse, improving care coordination, and enhancing healthcare quality and safety.
The document discusses several developments for treating inherited neuropathies:
1) The first gene therapy clinical trial to treat an inherited neuropathy, Giant Axonal Neuropathy, is approved. It will deliver a healthy copy of the GAN gene to spinal cord nerves using an AAV9 viral vector.
2) The Hereditary Neuropathy Foundation is creating a directory of expert healthcare providers for Charcot-Marie-Tooth and providing them resources to improve diagnosis and care.
3) An advisory board meeting was held to discuss the Foundation's research funding to date and future goals, including several projects aimed at developing treatments for CMT and related diseases.
Use of Genetic Databases to Advance Diagnostic Test DevelopmentEMMAIntl
In December 2018, the U.S. Food and Drug Administration formally recognized a public database that contains information about genes, genetic variants, and their relationship to disease. This blog discusses the motivation for creating such public databases and the implications for developers of genetic tests...
Genetics is becoming more personalized with direct-to-consumer genetic testing services like 23andMe. 23andMe analyzes customers' DNA samples and provides information about their ancestry, traits, and disease risks through an online platform. This empowers individuals and facilitates research by creating a large participant network. While challenges remain in fully engaging all stakeholders, personalized genetics has the potential to transform healthcare by better targeting treatment to individual genetics.
This workshop is designed to talk about the impact of STDs on youth under the age of 25. This workshop will discuss the importance of sexual health screenings, partner management, and current data around STD morbidity rates. We will also talk about current STD clinical recommendations for the treatment of gonorrhea, chlamydia, and syphilis. Participants will engage in an interactive activity where they will sharpen their skills on effective partner management strategies.
Cancer principles & practice of oncologySAMANTHA Lopez
This chapter provides an overview of cancer genetic counseling. Cancer genetic counseling is a communication process that assesses an individual's cancer risk based on their family history of cancer. The goals are to provide clients with an understanding of their risk, emotional support, and determine if cancers in the family could be due to a hereditary cancer syndrome. There are over 30 hereditary cancer syndromes that can be caused by mutations in different genes, so genetic testing for these syndromes can be complex. The chapter emphasizes that accurate cancer risk assessment and counseling requires specialized training.
4 Ways for Doctors to Avoid Inappropriate TestingBest Doctors
The document discusses 4 ways for doctors to avoid inappropriate medical tests by educating students and colleagues, advocating for administrative changes, engaging patients in treatment decisions, and building collaboration among peers to question unnecessary tests in order to address the large costs and risks associated with overtesting. Inappropriate testing wastes healthcare dollars, can delay accurate diagnoses, and potentially causes patient harm.
Similar to Consuming Genomes: Constructing the Genetic Consumer in the United States (20)
by Virginia Sanchini
Dipartimento di Oncologia ed Emato-Oncologia
Università degli Studi di Milano
Slide presentate per il seminario "Curare l'invecchiamento?" per il ciclo "Longevità e innovazione di Fondazione Giannino Bassetti e Fondazione Ravasi Garzanti.
Video, podcast, sintesi e fotografie sono reperibili nel nostro sito all'indirizzo https://www.fondazionebassetti.org/it/focus/2023/04/curare_linvecchiamento.html
di Sara Berloto, Elisabetta Notarnicola, Eleonora Perobelli, Andrea Rotolo (SDA Bocconi) per il corso "Longevità e innovazione responsabile" di Fondazione Bassetti e Fondazione Ravasi-Garzanti per la Scuola del design del Politecnico di Milano. 2021.
A questo link presentazione e podcast: https://www.fondazionebassetti.org/en/focus/2021/05/longevita_e_innovazione_respon.htm
MATTEO MAURI (Cooperativa La Meridiana di Monza) per il corso "Longevità e innovazione responsabile" di Fondazione Bassetti e Fondazione Ravasi-Garzanti per la Scuola del design del Politecnico di Milano. 2021.
A questo link presentazione e podcast: https://www.fondazionebassetti.org/en/focus/2021/05/longevita_e_innovazione_respon.html
CARLA PIERSANTI (Sportelli Curami & Proteggimi di Milano) per il corso "Longevità e innovazione responsabile" di Fondazione Bassetti e Fondazione Ravasi-Garzanti per la Scuola del design del Politecnico di Milano. 2021.
A questo link presentazione e podcast: https://www.fondazionebassetti.org/en/focus/2021/05/longevita_e_innovazione_respon.html
Adattamento della casa, automazione e domotica. Di Tiziana Cretti per il corso "Longevità e innovazione responsabile" di Fondazione Bassetti e Fondazione Ravasi-Garzanti per la Scuola del design del Politecnico di Milano. 2021.
A questo link presentazione e podcast: https://www.fondazionebassetti.org/en/focus/2021/05/longevita_e_innovazione_respon.html
L'assistenza della persona anziana. Di Federico Pennestrì per il corso "Longevità e innovazione responsabile" di Fondazione Bassetti e Fondazione Ravasi-Garzanti per la Scuola del design del Politecnico di Milano. 2021.
A questo link presentazione e podcast: https://www.fondazionebassetti.org/en/focus/2021/05/longevita_e_innovazione_respon.html
di Giampaolo Azzoni per il corso "Longevità e innovazione responsabile" di Fondazione Bassetti e Fondazione Ravasi-Garzanti per la Scuola del design del Politecnico di Milano. 2021
A questo link presentazione e podcast: https://www.fondazionebassetti.org/en/focus/2021/05/longevita_e_innovazione_respon.html
di Fiorella Operto per il corso "Longevità e innovazione responsabile" di Fondazione Bassetti e Fondazione Ravasi-Garzanti per la Scuola del design del Politecnico di Milano. 2021
https://www.fondazionebassetti.org/en/focus/2021/05/longevita_e_innovazione_respon.html
di Rosaria Iardino, presidente Fondazione The Bridge.
Slide utilizzate nella lecture del ciclo "La medicina di precisione: opportunità terapeutiche e responsabilità pubblica", tenuta in Fondazione Giannino Bassetti a giugno 2018.
Qui report e video: https://www.fondazionebassetti.org/it/focus/2018/08/la_sostenibilita_economica_del.html
di Pier Paolo Di Fiore, IEO - Istituto Europeo di Oncologia.
Slide utilizzate nella lecture del ciclo "La medicina di precisione: opportunità terapeutiche e responsabilità pubblica", tenuta in Fondazione Giannino Bassetti a giugno 2018.
Qui report e video: https://www.fondazionebassetti.org/it/focus/2018/08/la_sostenibilita_economica_del.html
di Chiara Demartini, University of Pavia and Fondazione IRCCS Policlinico San Matteo
Slide utilizzate nella lecture del ciclo "La medicina di precisione: opportunità terapeutiche e responsabilità pubblica", tenuta in Fondazione Giannino Bassetti a giugno 2018.
Qui report e video: https://www.fondazionebassetti.org/it/focus/2018/08/la_sostenibilita_economica_del.html
di Silvia Priori, Università di Pavia e Istituti Clinici Scientifici Maugeri IRCCS.
Slide utilizzate nella lecture del ciclo "La medicina di precisione: opportunità terapeutiche e responsabilità pubblica", tenuta in Fondazione Giannino Bassetti a maggio 2018.
Qui report e video: https://www.fondazionebassetti.org/it/focus/2018/08/la_medicina_di_precisione_in_c.html
di Gianluigi Zanetti
CRS4 - Centro di Ricerca, Sviluppo e Studi Superiori in Sardegna
Slide per l'incontro dal titolo "Big data, machine learning e medicina di precisione."
10 maggio 2018, Milano, Fondazione Giannino Bassetti
Video integrale: https://www.fondazionebassetti.org/it/focus/2018/08/big_data_machine_learning_e_me.html
di Matteo Santoro
Camelot Biomedical System
Slide per l'incontro dal titolo "Big data, machine learning e medicina di precisione."
10 maggio 2018, Milano, Fondazione Giannino Bassetti
Video integrale: https://www.fondazionebassetti.org/it/focus/2018/08/big_data_machine_learning_e_me.html
Our classification technique uses a deep CNN to classify skin lesions. An image is warped through the CNN architecture into a probability distribution over clinical skin disease classes. The CNN was pretrained on a large generic image dataset and fine-tuned on a dataset of over 129,000 skin lesions spanning 2,032 diseases. Data integration from multiple sources is key to future digital medicine, but challenges include data quality, availability, and privacy. Techniques like distributed learning models and homomorphic encryption can help address privacy concerns while enabling large-scale data sharing and analysis.
di Antonietta Mira
Director, Data Science Center Università della Svizzera italiana, Lugano
Professore di Statistica, Dipartimento di Scienza e Alta Tecnologia Università degli Studi dell’Insubria, Como
Slide per l'incontro dal titolo "Big data, machine learning e medicina di precisione."
10 maggio 2018, Milano, Fondazione Giannino Bassetti
video integrale: https://www.fondazionebassetti.org/it/focus/2018/08/big_data_machine_learning_e_me.html
di Angela Simone. Slide per l'intervento nell'incontro "Il nuovo ruolo dei pazienti nella medicina di precisione" (Milano, Fondazione Giannino Bassetti, 5 aprile 2018), secondo appuntamento del ciclo "La medicina di precisione: opportunità terapeutiche e responsabilità pubblica", prima espressione della collaborazione tra Università di Pavia e Fondazione Giannino Bassetti.
di Rosaria Iardino. Slide per l'intervento nell'incontro "Il nuovo ruolo dei pazienti nella medicina di precisione" (Milano, Fondazione Giannino Bassetti, 5 aprile 2018), secondo appuntamento del ciclo "La medicina di precisione: opportunità terapeutiche e responsabilità pubblica", prima espressione della collaborazione tra Università di Pavia e Fondazione Giannino Bassetti.
The document discusses precision medicine and genetic testing. It presents a hypothetical case in 2010 of a 23-year-old man named John who undergoes genetic testing to determine his risk for various diseases. The testing reveals both increased and decreased risks compared to the general population. John is able to take preventive measures, such as medication and lifestyle changes, to reduce his risk of diseases like heart disease and cancer based on his genetic results. The document also discusses ensuring public understanding and consent regarding genetic testing and precision medicine.
di Gampaolo Azzoni. Slide per l'intervento nell'incontro "Il nuovo ruolo dei pazienti nella medicina di precisione" (Milano, Fondazione Giannino Bassetti, 5 aprile 2018), secondo appuntamento del ciclo "La medicina di precisione: opportunità terapeutiche e responsabilità pubblica", prima espressione della collaborazione tra Università di Pavia e Fondazione Giannino Bassetti.
Reimagining Your Library Space: How to Increase the Vibes in Your Library No ...Diana Rendina
Librarians are leading the way in creating future-ready citizens – now we need to update our spaces to match. In this session, attendees will get inspiration for transforming their library spaces. You’ll learn how to survey students and patrons, create a focus group, and use design thinking to brainstorm ideas for your space. We’ll discuss budget friendly ways to change your space as well as how to find funding. No matter where you’re at, you’ll find ideas for reimagining your space in this session.
Strategies for Effective Upskilling is a presentation by Chinwendu Peace in a Your Skill Boost Masterclass organisation by the Excellence Foundation for South Sudan on 08th and 09th June 2024 from 1 PM to 3 PM on each day.
How to Make a Field Mandatory in Odoo 17Celine George
In Odoo, making a field required can be done through both Python code and XML views. When you set the required attribute to True in Python code, it makes the field required across all views where it's used. Conversely, when you set the required attribute in XML views, it makes the field required only in the context of that particular view.
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UPRAHUL
This Dissertation explores the particular circumstances of Mirzapur, a region located in the
core of India. Mirzapur, with its varied terrains and abundant biodiversity, offers an optimal
environment for investigating the changes in vegetation cover dynamics. Our study utilizes
advanced technologies such as GIS (Geographic Information Systems) and Remote sensing to
analyze the transformations that have taken place over the course of a decade.
The complex relationship between human activities and the environment has been the focus
of extensive research and worry. As the global community grapples with swift urbanization,
population expansion, and economic progress, the effects on natural ecosystems are becoming
more evident. A crucial element of this impact is the alteration of vegetation cover, which plays a
significant role in maintaining the ecological equilibrium of our planet.Land serves as the foundation for all human activities and provides the necessary materials for
these activities. As the most crucial natural resource, its utilization by humans results in different
'Land uses,' which are determined by both human activities and the physical characteristics of the
land.
The utilization of land is impacted by human needs and environmental factors. In countries
like India, rapid population growth and the emphasis on extensive resource exploitation can lead
to significant land degradation, adversely affecting the region's land cover.
Therefore, human intervention has significantly influenced land use patterns over many
centuries, evolving its structure over time and space. In the present era, these changes have
accelerated due to factors such as agriculture and urbanization. Information regarding land use and
cover is essential for various planning and management tasks related to the Earth's surface,
providing crucial environmental data for scientific, resource management, policy purposes, and
diverse human activities.
Accurate understanding of land use and cover is imperative for the development planning
of any area. Consequently, a wide range of professionals, including earth system scientists, land
and water managers, and urban planners, are interested in obtaining data on land use and cover
changes, conversion trends, and other related patterns. The spatial dimensions of land use and
cover support policymakers and scientists in making well-informed decisions, as alterations in
these patterns indicate shifts in economic and social conditions. Monitoring such changes with the
help of Advanced technologies like Remote Sensing and Geographic Information Systems is
crucial for coordinated efforts across different administrative levels. Advanced technologies like
Remote Sensing and Geographic Information Systems
9
Changes in vegetation cover refer to variations in the distribution, composition, and overall
structure of plant communities across different temporal and spatial scales. These changes can
occur natural.
Beyond Degrees - Empowering the Workforce in the Context of Skills-First.pptxEduSkills OECD
Iván Bornacelly, Policy Analyst at the OECD Centre for Skills, OECD, presents at the webinar 'Tackling job market gaps with a skills-first approach' on 12 June 2024
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...PECB
Denis is a dynamic and results-driven Chief Information Officer (CIO) with a distinguished career spanning information systems analysis and technical project management. With a proven track record of spearheading the design and delivery of cutting-edge Information Management solutions, he has consistently elevated business operations, streamlined reporting functions, and maximized process efficiency.
Certified as an ISO/IEC 27001: Information Security Management Systems (ISMS) Lead Implementer, Data Protection Officer, and Cyber Risks Analyst, Denis brings a heightened focus on data security, privacy, and cyber resilience to every endeavor.
His expertise extends across a diverse spectrum of reporting, database, and web development applications, underpinned by an exceptional grasp of data storage and virtualization technologies. His proficiency in application testing, database administration, and data cleansing ensures seamless execution of complex projects.
What sets Denis apart is his comprehensive understanding of Business and Systems Analysis technologies, honed through involvement in all phases of the Software Development Lifecycle (SDLC). From meticulous requirements gathering to precise analysis, innovative design, rigorous development, thorough testing, and successful implementation, he has consistently delivered exceptional results.
Throughout his career, he has taken on multifaceted roles, from leading technical project management teams to owning solutions that drive operational excellence. His conscientious and proactive approach is unwavering, whether he is working independently or collaboratively within a team. His ability to connect with colleagues on a personal level underscores his commitment to fostering a harmonious and productive workplace environment.
Date: May 29, 2024
Tags: Information Security, ISO/IEC 27001, ISO/IEC 42001, Artificial Intelligence, GDPR
-------------------------------------------------------------------------------
Find out more about ISO training and certification services
Training: ISO/IEC 27001 Information Security Management System - EN | PECB
ISO/IEC 42001 Artificial Intelligence Management System - EN | PECB
General Data Protection Regulation (GDPR) - Training Courses - EN | PECB
Webinars: https://pecb.com/webinars
Article: https://pecb.com/article
-------------------------------------------------------------------------------
For more information about PECB:
Website: https://pecb.com/
LinkedIn: https://www.linkedin.com/company/pecb/
Facebook: https://www.facebook.com/PECBInternational/
Slideshare: http://www.slideshare.net/PECBCERTIFICATION
How to Manage Your Lost Opportunities in Odoo 17 CRMCeline George
Odoo 17 CRM allows us to track why we lose sales opportunities with "Lost Reasons." This helps analyze our sales process and identify areas for improvement. Here's how to configure lost reasons in Odoo 17 CRM
This presentation was provided by Steph Pollock of The American Psychological Association’s Journals Program, and Damita Snow, of The American Society of Civil Engineers (ASCE), for the initial session of NISO's 2024 Training Series "DEIA in the Scholarly Landscape." Session One: 'Setting Expectations: a DEIA Primer,' was held June 6, 2024.
Chapter wise All Notes of First year Basic Civil Engineering.pptxDenish Jangid
Chapter wise All Notes of First year Basic Civil Engineering
Syllabus
Chapter-1
Introduction to objective, scope and outcome the subject
Chapter 2
Introduction: Scope and Specialization of Civil Engineering, Role of civil Engineer in Society, Impact of infrastructural development on economy of country.
Chapter 3
Surveying: Object Principles & Types of Surveying; Site Plans, Plans & Maps; Scales & Unit of different Measurements.
Linear Measurements: Instruments used. Linear Measurement by Tape, Ranging out Survey Lines and overcoming Obstructions; Measurements on sloping ground; Tape corrections, conventional symbols. Angular Measurements: Instruments used; Introduction to Compass Surveying, Bearings and Longitude & Latitude of a Line, Introduction to total station.
Levelling: Instrument used Object of levelling, Methods of levelling in brief, and Contour maps.
Chapter 4
Buildings: Selection of site for Buildings, Layout of Building Plan, Types of buildings, Plinth area, carpet area, floor space index, Introduction to building byelaws, concept of sun light & ventilation. Components of Buildings & their functions, Basic concept of R.C.C., Introduction to types of foundation
Chapter 5
Transportation: Introduction to Transportation Engineering; Traffic and Road Safety: Types and Characteristics of Various Modes of Transportation; Various Road Traffic Signs, Causes of Accidents and Road Safety Measures.
Chapter 6
Environmental Engineering: Environmental Pollution, Environmental Acts and Regulations, Functional Concepts of Ecology, Basics of Species, Biodiversity, Ecosystem, Hydrological Cycle; Chemical Cycles: Carbon, Nitrogen & Phosphorus; Energy Flow in Ecosystems.
Water Pollution: Water Quality standards, Introduction to Treatment & Disposal of Waste Water. Reuse and Saving of Water, Rain Water Harvesting. Solid Waste Management: Classification of Solid Waste, Collection, Transportation and Disposal of Solid. Recycling of Solid Waste: Energy Recovery, Sanitary Landfill, On-Site Sanitation. Air & Noise Pollution: Primary and Secondary air pollutants, Harmful effects of Air Pollution, Control of Air Pollution. . Noise Pollution Harmful Effects of noise pollution, control of noise pollution, Global warming & Climate Change, Ozone depletion, Greenhouse effect
Text Books:
1. Palancharmy, Basic Civil Engineering, McGraw Hill publishers.
2. Satheesh Gopi, Basic Civil Engineering, Pearson Publishers.
3. Ketki Rangwala Dalal, Essentials of Civil Engineering, Charotar Publishing House.
4. BCP, Surveying volume 1
spot a liar (Haiqa 146).pptx Technical writhing and presentation skills
Consuming Genomes: Constructing the Genetic Consumer in the United States
1. Consuming Genomes: Constructing the Genetic Consumer in the United States FondazioneGianninoBassetti 16 May 2011 Margaret Curnutte European School of Molecular Medicine (SEMM) at the Campus IFOM-IEO (Milano), University of Milano & Harvard Program on Science, Technology & Society
First to tell you why DTC genetic testing is particularly a matter for social investigation Projections for personalized medicine and the decreasing cost of sequencing technology. What could this mean for companies that are currently offering comprehensive SNP analysis? I refer to an article in the NYTimes:
Based in Silicon Valley. Founded April 2006: Linda Avey and Anne Wojcicki Interesting note: wife of Sergey Brin, co-founder of Google Not a coincidence that Google is a primary investor
Backed by venture capital group, Kleiner Perkins Caufield & Byers: Amazon, Sun, Genentech, Intuit Navigenics was launched: Nov. 2007 by David Agus and Dietrich Stephan Tagline: There is DNA, the raw molecular material, and there is the additional intellectual property that is part of genetic tests which is necessary to produce genetic knowledge. The you in the statement to some extent undermines the additional players involved in the development of genetic tests and subequent genetic knowledge.